Form D · Other
DeVoro Medical Inc.
Fremont, CA · CIK 0001785899
Offering snapshot reported Jul 6, 2020 · SEC filing
- Reported sold
- $18M Offering amount: $18M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 22, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 6, 2020 | Initial | $17,999,945 | No comparison | 6 | SEC filing |
| Aug 21, 2019 | Initial | $8,498,427 | No comparison | 16 | SEC filing |
| Aug 21, 2019 | Amendment | $8,498,427 | $0vs Aug 21, 2019 | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-370209
Source: Form D, filed Jul 6, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Casper De Clercq | Director |
| Erik Engelson | Director |
| Skott Greenhalgh | Director |
| Michael Wallace | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
48389 Fremont Blvd.
Fremont, CA, 94538
Fremont, CA, 94538